Last Posted: Oct 21, 2018
- Every Woman Study,
World Ovarian Cancer Coalition Survey, 2018 - Report: Women Everywhere Don't Know Enough About Ovarian Cancer
J Silberner, NPR, October 21, 2018 - Personalised medicine and population health: breast and ovarian cancer.
Narod Steven A et al. Human genetics 2018 Oct - Contributions of Public Health in Reducing the Population Burden of Familial Hypercholesterolemia: Challenges and Opportunities
MJ Khoury et al, CDC Blog Post, October 17, 2018 - Familial breast cancer and DNA repair genes: insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing.
Girard Elodie et al. International journal of cancer 2018 Oct - Germline pathogenic variants identified in women with ovarian tumors.
Carter Natalie J et al. Gynecologic oncology 2018 Oct - Moving From Mutation to Actionability.
Colombo Ilaria et al. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2018 May (38) 495-503 - Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings.
Bonache Sandra et al. Journal of cancer research and clinical oncology 2018 Oct - Perspectives from a state genetics coordinator: Public health’s role in addressing familial hypercholesterolemia (FH) in the United States
Deb Lochner Doyle, Blog Post, October 17, 2018 - A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.
Hoskins Kent F et al. Cancer 2018 Oct
.png)
No hay comentarios:
Publicar un comentario